Stock 300966 HUBEI GOTO BIOPHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Hubei Goto Biopharm Co.,Ltd.

Equities

300966

CNE100004K94

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 22/05/2024 am IST 		5-day change 1st Jan Change
19.65 CNY +2.29% Intraday chart for Hubei Goto Biopharm Co.,Ltd. -4.61% -14.45%
26/04 Hubei Goto Biopharm Co.,Ltd. Proposes Final Cash Dividend for 2023 CI
25/04 Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hubei Goto Biopharm Co.,Ltd. Proposes Final Cash Dividend for 2023
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Certain A Shares of Hubei Goto Biopharm Co.,Ltd. are subject to a Lock-Up Agreement Ending on 9-APR-2024.
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Hubei Goto Biopharm Issues $53 Million Convertible Bonds
MT
Hubei Goto Biopharm to Guarantee 46% of Unit’s Loan
MT
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Hubei Goto Biopharm Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 31 May 2022
CI
Hubei Goto Biopharm Co.,Ltd. Approves Cash Dividend for 2021
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Hubei Goto Biopharm Co.,Ltd. Proposes Cash Dividend for 2021
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Certain A Shares of Hubei Goto Biopharm Co.,Ltd. are subject to a Lock-Up Agreement Ending on 9-APR-2022.
CI
Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Hubei Goto Biopharm Co.,Ltd. Announces Executive Changes
CI
Hubei Goto Biopharm : to List 1.5 Million Shares Post IPO Lockup; Shares Jump 4%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300966 Stock
  4. News Hubei Goto Biopharm Co.,Ltd.